Trust CO Of Vermont Alkermes Plc. Transaction History

Trust CO Of Vermont

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$26.4 - $30.54 $26,400 - $30,540	1,000 New	1,000 $30,000
Q1 2022 Apr 05, 2022	SELL	$23.07 - $27.99 $23,070 - $27,990	-1,000 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$21.47 - $32.08 $21,470 - $32,080	1,000 New	1,000 $23,000
Q3 2021 Oct 22, 2021	SELL	$23.37 - $32.13 $23,370 - $32,130	-1,000 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$13.31 - $19.41 $13,310 - $19,410	1,000 New	1,000 $19,000
Q4 2017 Feb 02, 2018	SELL	$47.69 - $55.39 $2,432 - $2,824	-51 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$49.16 - $54.45 $2,507 - $2,776	51	51 $3,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.55B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.